RANBP2 may mainly promote HCC malignancy by regulating the O-GlcNAc-associated enzyme OGA; however, whether CEBPα is a crucial intermediate in RANBP2-associated aberrant O-glycosylation needs to be further investigated. Here, CEBPA is linked to hepatocellular carcinoma.